Evaluation and validation of the prognostic value of anti-MDA5 IgG subclasses in dermatomyositis-associated interstitial lung disease.

Yue-Tong XuYa-Mei ZhangHong-Xia YangLi-Fang YeFang ChenXin LuGuo-Chun WangQing-Lin Peng

Published in: Rheumatology (Oxford, England) (2022)

Anti-MDA5 IgG1 and IgG3 are significantly associated with poor prognosis in DM-ILD patients, and anti-MDA5 IgG1 is more efficient as a prognostic biomarker in DM-ILD patients.

Keyphrases

interstitial lung disease
poor prognosis
systemic sclerosis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
rheumatoid arthritis
long non coding rna
peritoneal dialysis
adipose tissue
clinical evaluation